MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC DPO Ratio 2011-2026 | OXFD
Annual DPO Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 45.8 | 60.8 | 53.4 | 29.6 | 46.9 | 36 | 45.3 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 60.8 | 29.6 | 45.4 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 203.06 | - | $ 22.5 B | USA |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
4.24 K | $ 4.29 | - | $ 5.71 M | USA |
 |
Castle Biosciences
CSTL
|
65.8 | $ 20.7 | - | $ 600 M | USA |
 |
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
196 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
35.2 | $ 18.68 | -0.53 % | $ 575 M | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
48.6 | $ 131.62 | - | $ 16.5 B | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 22.97 | - | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
11 | $ 146.18 | - | $ 11.5 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
33 | $ 1.6 | -3.03 % | $ 7.08 M | USA |
 |
Illumina
ILMN
|
57.1 | $ 160.97 | - | $ 25 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
23.6 | $ 104.52 | - | $ 7.05 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 187.51 | - | $ 9.29 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
13.3 | $ 467.34 | -1.63 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 131.49 | - | $ 23.3 B |  Schweiz |
 |
NeoGenomics
NEO
|
19.7 | $ 11.15 | - | $ 1.43 B | USA |
 |
Myriad Genetics
MYGN
|
45.9 | $ 4.33 | - | $ 401 M | USA |
 |
National Research Corporation
NRC
|
10.1 | $ 18.79 | - | $ 421 M | USA |
 |
Natera
NTRA
|
17.9 | $ 212.07 | - | $ 29 B | USA |
 |
Pacific Biosciences of California
PACB
|
59.7 | $ 1.31 | - | $ 393 M | USA |
 |
Personalis
PSNL
|
65.7 | $ 9.59 | - | $ 856 M | USA |
 |
Senseonics Holdings
SENS
|
68 | $ 7.18 | - | $ 300 M | USA |
 |
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
1.44 K | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.05 | - | $ 4.71 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 266.16 | - | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
12.5 | $ 76.17 | - | $ 4.56 B | USA |
 |
Thermo Fisher Scientific
TMO
|
49.3 | $ 469.34 | 0.1 % | $ 177 B | USA |
 |
Trinity Biotech plc
TRIB
|
163 | $ 0.65 | - | $ 233 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
62.7 | $ 9.1 | -1.57 % | $ 1.97 B | USA |
 |
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | USA |